Beimei Pharma Overview
- Year Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
Series C
- Investors
-
7
Beimei Pharma General Information
Description
Provider and developer of drugs designed for pediatric prescription medicines. The company focuses on the field of chemical prescription drugs for children, and the company's product pipeline is mainly distributed in the respiratory system, anti-infection, nervous system, digestive system and other fields, providing patients with high quality pediatric medicines.
Contact Information
Website
www.beimeiyaoye.comCorporate Office
- Room 1501, 1502, 1503, 1505, Floor 15 of Unit 1, Building A, Kexing Science Park
- Keyuan Road, Nanshan High-tech Zone, Nanshan District
- Shenzhen, Guangdong 518000
- China
Corporate Office
- Room 1501, 1502, 1503, 1505, Floor 15 of Unit 1, Building A, Kexing Science Park
- Keyuan Road, Nanshan High-tech Zone, Nanshan District
- Shenzhen, Guangdong 518000
- China
Beimei Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 21-Jul-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 01-Mar-2022 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 26-Jan-2021 | $1.48M | Completed | Generating Revenue | ||
| 1. Angel (individual) | 01-Mar-2019 | $1.48M | $1.48M | Completed | Generating Revenue |
Beimei Pharma Patents
Beimei Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026045047-A1 | Cefcapene pivoxil hydrochloride granule and preparation method therefor | Pending | 26-Aug-2024 | ||
| WO-2025036496-A1 | Oral thin film comprising lurasidone | Inactive | 17-Aug-2023 | ||
| WO-2024234674-A1 | Pharmaceutical liquid composition, and preparation method therefor and use thereof | Inactive | 17-May-2023 | ||
| WO-2024178796-A1 | Crisaborole aerosol and preparation method therefor | Inactive | 01-Mar-2023 | ||
| WO-2024178795-A1 | External aerosol and preparation method therefor | Inactive | 01-Mar-2023 | A61K9/12 |
Beimei Pharma Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jiangsu Aosaikang Pharmaceutical | Corporation | Minority | ||
| Jiangsu Jinqiao Private Equity Fund Management | Growth/Expansion | Minority | ||
| Shenzhen Nanshan Strategic Emerging Industry Investment | Government | Minority | ||
| Shenzhen Lianrun Oriental Equity Investment Fund Management | Growth/Expansion | Minority | ||
| Shenzhen Yifeng Investment Management Enterprise | Venture Capital | Minority |
Beimei Pharma FAQs
-
When was Beimei Pharma founded?
Beimei Pharma was founded in 2010.
-
Where is Beimei Pharma headquartered?
Beimei Pharma is headquartered in Shenzhen, China.
-
What industry is Beimei Pharma in?
Beimei Pharma’s primary industry is Pharmaceuticals.
-
Is Beimei Pharma a private or public company?
Beimei Pharma is a Private company.
-
What is the current valuation of Beimei Pharma?
The current valuation of Beimei Pharma is .
-
What is Beimei Pharma’s current revenue?
The current revenue for Beimei Pharma is .
-
How much funding has Beimei Pharma raised over time?
Beimei Pharma has raised $17.2M.
-
Who are Beimei Pharma’s investors?
Jiangsu Aosaikang Pharmaceutical, Jiangsu Jinqiao Private Equity Fund Management, Shenzhen Nanshan Strategic Emerging Industry Investment, Shenzhen Lianrun Oriental Equity Investment Fund Management, and Shenzhen Yifeng Investment Management Enterprise are 5 of 7 investors who have invested in Beimei Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process